Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age-Reference-Cited by-同舟云学术

Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age

Published:2017-11 Issue:47 Volume:35 Page:6355-6358
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Halstead Scott B.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference26 articles.

1. Dengue vaccine safety signal: immune enhancement, waning immunity, or chance occurrence?;Gessner;Vaccine,2017

2. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease;Hadinegoro;N Engl J Med,2015

3. Dengue vaccine: hypotheses to understand CYD-TDV-induced protection;Guy;Nat Rev Microbiol,2016

4. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection;Guzman;Arch Virol,2013

5. Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naive and dengue-exposed individuals;Henein;J Infect Dis.,2017

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An In Silico Design of a Vaccine against All Serotypes of the Dengue Virus Based on Virtual Screening of B-Cell and T-Cell Epitopes;Biology;2024-08-30

2. A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine;Cell Reports;2024-07

3. Dual action effects of ethyl-p-methoxycinnamate against dengue virus infection and inflammation via NF-κB pathway suppression;Scientific Reports;2024-04-23

4. A 2D-proteomic analysis identifies proteins differentially regulated by two different dengue virus serotypes;Scientific Reports;2024-04-09

5. Reiseimpfungen – Hinweise und Empfehlungen;Flugmedizin · Tropenmedizin · Reisemedizin - FTR;2024-04